Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hepatocellular carcinoma.
Forner A, Llovet JM, Bruix J. Forner A, et al. Among authors: llovet jm. Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20. Lancet. 2012. PMID: 22353262 Review.
Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma.
Cubiella J, Sans M, Llovet JM, Bustamante J, Ferrer A, Caballeria J, Rodés J. Cubiella J, et al. Among authors: llovet jm. Am J Gastroenterol. 1997 Oct;92(10):1942-3. Am J Gastroenterol. 1997. PMID: 9382078
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J. Llovet JM, et al. Hepatology. 1998 Jun;27(6):1572-7. doi: 10.1002/hep.510270616. Hepatology. 1998. PMID: 9620329
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.
Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, Vilana R, Rodés J. Bruix J, et al. Among authors: llovet jm. Hepatology. 1998 Jun;27(6):1578-83. doi: 10.1002/hep.510270617. Hepatology. 1998. PMID: 9620330 Clinical Trial.
Hepatocellular carcinoma.
Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, Meyers WC. Akriviadis EA, et al. Among authors: llovet jm. Br J Surg. 1998 Oct;85(10):1319-31. doi: 10.1046/j.1365-2168.1998.00865.x. Br J Surg. 1998. PMID: 9782009 Review.
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.
Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 1999 Jan;29(1):62-7. doi: 10.1002/hep.510290145. Hepatology. 1999. PMID: 9862851 Clinical Trial.
Sclerosing hepatic carcinoma in non-cirrhotic liver resembling metastatic adenocarcinoma.
Llovet JM, Miquel R. Llovet JM, et al. J Hepatol. 1999 Jan;30(1):161. doi: 10.1016/s0168-8278(99)80021-x. J Hepatol. 1999. PMID: 9927164 No abstract available.
Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Llovet JM, Brú C, Bruix J. Llovet JM, et al. Semin Liver Dis. 1999;19(3):329-38. doi: 10.1055/s-2007-1007122. Semin Liver Dis. 1999. PMID: 10518312
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.
Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629. Hepatology. 1999. PMID: 10573522
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.
Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas V, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 2000 Jan;31(1):54-8. doi: 10.1002/hep.510310111. Hepatology. 2000. PMID: 10613728 Clinical Trial.
282 results
Jump to page
Feedback